Sector pending / In Vitro and In Vivo Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

KOSDAQ/304840 stock hub

KOSDAQ/304840 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/304840is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

30.2B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/304840

In the news

Latest news · KOSDAQ/304840

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-69.2

P25 n/aP50 n/aP75 n/a

ROIC-28.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/304840 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

155

Groups with data

Currency

KRW

Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Enterprise value	KRW 38.2B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	In Vitro and In Vivo Diagnostic Substances
Last refreshed	2026-05-10
Market cap	KRW 30.2B
Price	KRW 1,289
Price currency	KRW
Sic	2835
Symbol	kosdaq/304840
Website	https://www.peoplebio.net

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-52.06%
EV Earnings	-2.43x
EV/FCF	-7.07x
EV/Sales	13.39x
FCF yield	-17.88%
P/B ratio	1.05x
P/S ratio	10.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-16.72%
Gross Profit	KRW -476.5M
Net Income	KRW -15.7B
Pretax Margin	-440.11%
ROA	-21.28
Roa5y	-19.72
ROCE	-39.92
ROE	-69.24
Roe5y	-85.62
ROIC	-28.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-53.93%
Cagr3y	-45.64%
Cagr5y	-40.65%
Revenue Growth	12.64x
Revenue Growth3 Y	-13.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.08
Assets	KRW 44.6B
Cash	KRW 80.1M
Current Assets	KRW 4.4B
Current Liabilities	KRW 14B
Debt	KRW 7.8B
Debt Equity	KRW 0.27
Debt FCF	KRW -1.44
Equity	KRW 28.6B
Interest Coverage	-4.52
Liabilities	KRW 16B
Long Term Assets	KRW 40.2B
Long Term Liabilities	KRW 1.9B
Net Cash	KRW -7.7B
Net Cash By Market Cap	KRW -25.43
Net Debt Equity	KRW 0.27
Tangible Book Value	KRW 28.3B
Tangible Book Value Per Share	KRW 1,303
WACC	12

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.31
Inventory Turnover	1.47
Net Working Capital	KRW -2B
Quick ratio	0.1
Working Capital	KRW -9.7B
Working Capital Turnover	KRW -0.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-53.9%
200-day SMA	1,484.6
3Y total return	-83.94%
50-day SMA	1,020.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.63%
All Time High	36,750
All Time High Change	-96.34%
All Time High Date	2020-11-06
All Time Low	600
All Time Low Change	124.33%
All Time Low Date	2026-03-04
ATR	131.1
Beta	0.69
Beta1y	1.41
Beta2y	0.21
Ch YTD	25.91
High	1,364
High52	2,970
High52 Date	2025-07-21
High52ch	-56.6%
Low	1,289
Low52	600
Low52 Date	2026-03-04
Low52ch	114.83%
Ma50ch	31.94%
Price vs 200-day SMA	-9.33%
RSI	53.12
RSI Monthly	37.5
RSI Weekly	50.25
Sharpe ratio	-0.47x
Sortino ratio	-0.66
Total Return	-0.11%
Tr YTD	25.91
Tr1m	78.75%
Tr1w	0.15%
Tr3m	24.98%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -12.2B
Operating margin	-427.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20,492,755%
Net Borrowing	-1,353,432,000
Shares Insiders	9.46%
Shares Out	23,416,791
Shares Yo Y	0.11%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -5.4B
Average Volume	1,586,606x
Bv Per Share	1,302.9
CAPEX	KRW -213.6M
Ch1m	78.75
Ch1w	0.15
Ch1y	-53.9
Ch3m	24.98
Ch3y	-86.14
Ch5y	-93.64
Ch6m	-13.05
Change	-4.23%
Change From Open	-1.6
Close	1,346
Days Gap	-2.67
Depreciation Amortization	1,746,690,210
Dollar Volume	115,721,264
Earnings Date	2026-04-03
EBIT	KRW -12.2B
EBITDA	KRW -10.4B
EPS	KRW -722
F Score	1
FCF	KRW -5.4B
FCF EV Yield	-14.14x
FCF Per Share	KRW -230
Financing CF	-1,353,432,000
Fiscal Year End	December
Founded	2,002
Investing CF	5,354,314,690
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-12-31
Last Split Date	2023-10-23
Last Split Type	Forward
Ma150	1,277.8
Ma150ch	5.34%
Ma20	1,368.3
Ma20ch	-1.63%
Net CF	-1,181,646,140
Open	1,310
Position In Range	0
Ppne	35,605,600,000
Price Date	2026-05-08
Ptbv Ratio	1.07
Relative Volume	0.06x
Revenue	2,850,535,920x
Tr6m	-13.05%
Volume	89,776
Z Score	-2.27

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KOSDAQ/304840 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/304840 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/304840?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+9.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

KOSDAQ/304840 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.1

Neutral momentum band

Price vs 200-day MA

-9.3%

50/200-day relationship not available

Beta (5Y)

0.69

Less volatile than the market

Sharpe ratio

-0.47

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/304840

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/304840 stock rating?

kosdaq/304840 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/304840 analysis?

The full report lives at /stocks/kosdaq/304840/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/304840?

The latest report frames kosdaq/304840 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/304840 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.